Pronađeno: 1-3 / 3 radova

Autori: Korsholm Lars

>> Filter: Samo Article i Review

Naslov A New Dosing Model Based on Body Mass Index to Guide Factor VIII Dosing in Patients with Hemophilia A (Meeting Abstract)
Autori Tiede Andreas  Goldmann Georg  Miljic Predrag S  Korsholm Lars  Matytsina Irina  Persson Paula  Jelev Lissitchkov Toshko 
Info BLOOD, (2018), vol. 132 br. , Suppl. 1, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial (Article)
Autori Lentz Steven R  Janic Dragana M  Kavakli Kaan  Miljic Predrag S  Oldenburg Johannes  Ozelo Margareth Castro  Santagostino Elena  Suzuki Takashi  Zupancic-Salek Silva  Korsholm Lars  Matytsina Irina  Tiede Andreas 
Info HAEMOPHILIA, (2018), vol. 24 br. 6, str. E391-E394
Projekat Novo Nordisk A/S
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2 (Meeting Abstract)
Autori Tiede Andreas  Janic Dragana M  Ozelo M  Santagostino E  Korsholm Lars  Matytsina Irina  Lentz SR 
Info HAEMOPHILIA, (2018), vol. 24 br. , Suppl. S1, str. 52-52
Projekat Alnylam; Baxter/Baxalta/Shire; Bayer; Biogen Idec; Biotest; CSL Behring; Novo Nordisk A/S; Octapharma; Pfizer; Roche; Sobi; Baxter; Shire
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX